Mycobacterium Tuberculosi (= Bcg) (= Bacillus Calmette-Guerin) shortage — BE supply status & alternatives

Mycobacterium Tuberculosi (= Bcg) (= Bacillus Calmette-Guerin)

—

In supply · Australia

BCG-Medac i.vesic. susp. flac

In supply · 🇦🇺 Australia · short in🇧🇪 BE🇳🇴 NO

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Mycobacterium Tuberculosi (= Bcg) (= Bacillus Calmette-Guerin)
Brand names	BCG-Medac i.vesic. susp. flac
Therapeutic category	Auto-created by Federal Agency for Medicines and Health Products — PharmaStatus scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~4 months

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇧🇪

FAMHP · 7h ago

High

🇳🇴

Norway

NOMA · 3d ago

Resolved

Verified timeline regulator events

🇳🇴 14 Aug 2026

medium reported

🇳🇴 9 Sept 2025

Shortage resolved

🇧🇪 1 Aug 2020

high reported

Sources official regulators

🇧🇪

FAMHP

verified 7h ago

verify ↗

🇳🇴

NOMA

verified 3d ago

verify ↗

Mederti Drug Report

Generated 2 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.